Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANTEOTECH LTD Investor Presentation 2012

Mar 15, 2012

64304_rns_2012-03-15_635673ba-2627-4191-b503-194d5bc39abe.pdf

Investor Presentation

Open in viewer

Opens in your device viewer

==> picture [211 x 115] intentionally omitted <==

16[th] March 2012

Company’s Announcement Office ASX Limited Exchange Centre 20 Bridge Street Sydney NSW 2000

ASX ANNOUNCEMENT / MEDIA RELEASE BOARDROOM RADIO INTERVIEW

ANTEO DIAGNOSTICS LIMITED (ADO) provides the opportunity to view a webcast with Dr. Geoff Cumming, Chief Executive Officer in a presentation titled "Anteo sign Agreement with eBioscience”.

To view , copy the following details into your web browser: http://www.brrmedia.com/event/95070

The presentation details are as follows:

  • Anteo sign Agreement with eBioscience

Presented by Dr. Geoff Cumming, Chief Executive Officer

  • Friday, 16 March 2012 9:30am AEST

For further information please contact:

Dr Geoff Cumming, CEO, Anteo Diagnostics Limited

Tel: +612 8823 3110

Anteo Diagnostics Limited ABN 75 070 028 625 Unit 4, 26 Brandl Street, Eight Mile Plains Qld 4113 Phone 07 3219 0085 Fax 07 3219 0553 Email [email protected] Web www.anteodx.com